SMYD3 and cancer: In order to identify novel potential SMYD3 interactors related to the “deregulating cellular energetics” cancer hallmark, we analyzed in silico the comprehensive Metabolism Reactome pathway (Reactome Id: R-HSA-1430728.10), which comprises 2,146 proteins (Table 1).